metricas
covid
Neurology perspectives Very late-onset membranous nephropathy secondary to alemtuzumab in a patient wit...
Journal Information

Statistics

Follow this link to access the full text of the article

Scientific letter
Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis
Nefropatía membranosa muy tardía secundaria a alemtuzumab en paciente con esclerosis múltiple
Z.F. Anabela,
Corresponding author
anabelzf95@gmail.com

Corresponding author at: Hospital General Universitario de Castellón. Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Castelló, Spain.
, M.A. Gemac, C.E. Bonaventurab, P.R. Judithc
a Sección Neurología Hospital General de Castellón, Avinguda de Benicàssim, 128, 12004 Castelló de la Plana, Castelló, Spain
b Servicio Neurología, Unidad de Esclerosis Múltiple, Hospital Universitario y Politécnico La Fe, Avinguda de Fernando Abril Martorell, 106, 46026 Valencia, Spain
c Servicio Anatomía Patológica, Hospital Universitario y Politécnico La Fe, Avinguda de Fernando Abril Martorell, 106, 46026 Valencia, Spain
Read
1415
Times
was read the article
484
Total PDF
931
Total HTML
Share statistics
Article information
ISSN: 26670496
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 36 13 49
2025 11 75 69 144
2025 10 32 36 68
2025 9 38 37 75
2025 8 40 33 73
2025 7 72 41 113
2025 6 44 52 96
2025 5 45 36 81
2025 4 49 8 57
2025 3 44 6 50
2025 2 34 6 40
2025 1 47 7 54
2024 12 41 5 46
2024 11 60 9 69
2024 10 28 2 30
2024 9 32 12 44
2024 8 31 33 64
2024 7 38 15 53
2024 6 22 11 33
2024 5 41 9 50
2024 4 38 16 54
2024 3 35 12 47
2024 2 9 16 25
Show all

Follow this link to access the full text of the article